Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Soloway

Showing results (101-110 of 307) with videos related to

Pageof 31
Sort By:
Seminars in Urologic Oncology|May 1, 1996
Neoadjuvant hormonal treatment before radical prostatectomyR B Watson, M S Soloway
World Journal of Urology|January 1, 1997
The role of nuclear matrix protein 22 in the detection of persistent or recurrent transitional-cell cancer of the bladderS W Shelfo, M S Soloway
British Journal of Urology|March 1, 1996
Induction androgen deprivation therapy before radical prostatectomy for prostate cancer--initial resultsF Abbas, M Kaplan, M S Soloway
The Journal of Urology|November 1, 1986
Pre-treatment testosterone levels: significance in androgen deprivation therapyD Hickey, B Todd, M S Soloway
Urology|December 1, 1978
Role of nurse clinician in urologic oncologyM S Soloway, M Ikard, M Tidwell
Urology|July 1, 1984
Estramustine phosphate--hormone, chemotherapeutic agent, or both?Y Walzer, J Oswalt, M S Soloway
BJU International|June 8, 2004
Concurrent radical retropubic prostatectomy and inguinal hernia repair through a modified Pfannenstiel incisionM Manoharan, P Gomez, M S Soloway
Urology|March 1, 1990
Dose response relationship of methotrexate in combination with cisplatin in murine bladder cancerM Brausi, A Blatnik, M S Soloway
Urology|January 1, 1988
Failure of chemotherapy to prolong life in patients with metastatic prostate cancer who have failed androgen deprivationD Hickey, J Cant, M S Soloway
Urology|February 1, 1983
Urothelial susceptibility to tumor cell implantation: comparison of cauterization with N-methyl-N-nitrosoureaM S Soloway, I Nissenkorn, L McCallum
Pageof 31

Showing results (101-110 of 307) with videos related to

Sort By:
Pageof 31
Seminars in Urologic Oncology|May 1, 1996
Neoadjuvant hormonal treatment before radical prostatectomyR B Watson, M S Soloway
World Journal of Urology|January 1, 1997
The role of nuclear matrix protein 22 in the detection of persistent or recurrent transitional-cell cancer of the bladderS W Shelfo, M S Soloway
British Journal of Urology|March 1, 1996
Induction androgen deprivation therapy before radical prostatectomy for prostate cancer--initial resultsF Abbas, M Kaplan, M S Soloway
The Journal of Urology|November 1, 1986
Pre-treatment testosterone levels: significance in androgen deprivation therapyD Hickey, B Todd, M S Soloway
Urology|December 1, 1978
Role of nurse clinician in urologic oncologyM S Soloway, M Ikard, M Tidwell
Urology|July 1, 1984
Estramustine phosphate--hormone, chemotherapeutic agent, or both?Y Walzer, J Oswalt, M S Soloway
BJU International|June 8, 2004
Concurrent radical retropubic prostatectomy and inguinal hernia repair through a modified Pfannenstiel incisionM Manoharan, P Gomez, M S Soloway
Urology|March 1, 1990
Dose response relationship of methotrexate in combination with cisplatin in murine bladder cancerM Brausi, A Blatnik, M S Soloway
Urology|January 1, 1988
Failure of chemotherapy to prolong life in patients with metastatic prostate cancer who have failed androgen deprivationD Hickey, J Cant, M S Soloway
Urology|February 1, 1983
Urothelial susceptibility to tumor cell implantation: comparison of cauterization with N-methyl-N-nitrosoureaM S Soloway, I Nissenkorn, L McCallum
Pageof 31